International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

2020/12/23 by Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel +47 · 265 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · Psychology · #Biochemistry #Biology #Cell biology #Computational biology #Function (biology) #Medicine #Neuroscience #Neurotransmitter Receptor Influence on Behavior #Nicotinic Acetylcholine Receptors Study #Pharmacology #Psychedelics and Drug Studies #Receptor

paper · pdf · doi:10.1124/pr.118.015552

published in Pharmacological Reviews 73(1), 310-520 (American Society for Pharmacology and Experimental Therapeutics)

openalex publication_date 2020/12/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Serotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination
• Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
• Mediation by 5‐hydroxytryptamine2Breceptors of endothelium‐dependent relaxation in rat jugular vein
• A Neurotrophic Model for Stress-Related Mood Disorders
• GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain
• Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
• Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
• Binding Sites for Bilobalide, Diltiazem, Ginkgolide, and Picrotoxinin at the 5-HT3 Receptor
• Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
• Recent advances in the phencyclidine model of schizophrenia

Cited by

• International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors
• A suite of engineered mice for interrogating psychedelic drug actions
• Structural basis of ligand recognition at the human MT 1 melatonin receptor. [europepmc]
• Tryptophan Metabolism and Gut-Brain Homeostasis. [europepmc]
• Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT 3 and 5-HT 6 Receptor Antagonist with Antipsychotic and Procognitive Properties. [europepmc]
• Molecular targets of psychedelic-induced plasticity. [europepmc]
• Tapping into 5-HT 3 Receptors to Modify Metabolic and Immune Responses. [europepmc]
• Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. [europepmc]
• 5-HT Receptors and Temperature Homeostasis. [europepmc]
• Rewiring of the Serotonin System in Major Depression. [europepmc]
• Sex-specific role for serotonin 5-HT 2A receptor in modulation of opioid-induced antinociception and reward in mice. [europepmc]
• The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. [europepmc]
• The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs. [europepmc]
• Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. [europepmc]
• Inactive and active state structures template selective tools for the human 5-HT 5A receptor. [europepmc]
• Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study. [europepmc]
• A unified hypothesis of SUDEP: Seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray. [europepmc]
• The crosstalk between 5-HT 2A R and mGluR2 in schizophrenia. [europepmc]
• Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease. [europepmc]
• Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism. [europepmc]
• Multiple modulatory roles of serotonin in chronic pain and injury-related anxiety. [europepmc]
• Latest updates on the serotonergic system in depression and anxiety. [europepmc]
• Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT 2A Receptor Agonists. [europepmc]
• Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. [europepmc]
• The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. [europepmc]
• Serotonin signaling to regulate energy metabolism: a gut microbiota perspective. [europepmc]
• Psychedelic control of neuroimmune interactions governing fear. [europepmc]